Lenskart Solut. Q1 FY27 Results & Concall Highlights: Revenue, Margins & Order Book
Published 25 Aug 2026 | Retailing | Market Cap: ₹1.2L Cr
India market expected to grow significantly as penetration is only about 35%, with rising myopia and new segments like progressives and premium frames opening opportunities. Lenskart expects continued volume-led growth, driven by increasing eye tests (up 42.7% in India) and store expansions.
From Lenskart Solut.'s Q1 FY27 earnings-call transcript · updated 25 Aug 2026.
Price
₹663
Market Cap
₹1.2L Cr
P/E Ratio
174.8
Revenue Rank
Margin Rank
How does Lenskart Solut. rank in Retailing?
Compare Lenskart Solut. against every Retailing company this quarter on revenue, margins and earnings-call signals.
Lenskart Solut. — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹2.5K Cr, net profit ₹204 Cr.
Full financials →📊 Revenue & Sales Performance
Rank 2- →India market expected to grow significantly as penetration is only about 35%, with rising myopia and new segments like progressives and premium frames opening opportunities.
- →Eye tests, a key driver, grew 23% recently, expanding the customer funnel as many discover vision issues for the first time.
- →International business aims for accelerated store additions in coming years, especially in markets like Thailand and Japan, with tech integration enabling scalable growth.
- →Same Store Sales Growth (SSSG) in India remains strong at around 18%, with increasing store density and sustained demand growth rather than share shifting.
- →Sunglasses and core prescription businesses are also volume-led, with international sunglasses showing strong seasonal peaks.
- →Continued focus on product margin expansion, supply chain integration, and backward integration to improve cost structure supports volume and revenue growth.
- →The company aims to build the vision correction market in India and internationally, not just compete within it, indicating long-term robust volume and revenue expansion.
📈 Profitability & Margins
Rank 3- →Lenskart expects continued volume-led growth, driven by increasing eye tests (up 42.7% in India) and store expansions.
- →India same-store sales growth (SSSG) remains strong at 18.3%, with store densification driving incremental demand.
- →International business is improving profitability with EBITDA pre-Ind AS margin crossing 10.6%, aiming for further Y-o-Y margin improvements despite seasonality.
- →Emphasis on expanding market penetration in India (only 35% penetration currently), broadening product range from affordable ₹500 glasses to premium ₹30,000+ offerings.
- →Continued investment in technology (remote/self eye tests, AI) to scale and improve operating efficiencies.
- →Operating cash flow conversion is high at 82% of EBITDA, supporting capex and positive net cash inflows.
- →Return on Capital Employed (ROCE) improved from 14% to 23%, showing disciplined capital allocation.
- →PAT growth accelerated 182% YoY this quarter, signaling strong bottom-line momentum.
- →Overall, Lenskart aims for accelerating growth, improving margins, and expanding market share with sustained profitability.
🏗️ Capital Expenditure Plans
Yes- →₹132 crores plant capex related to Hyderabad manufacturing facility (Page 7).
- →₹75 crores store capex to support store expansion (Page 7).
- →Continued investment in technology and engineering: building remote and self-eye tests, AI-enabled R&D for progressive lenses, and supply chain integration (Pages 15, 13).
- →Capital allocation aimed at scaling manufacturing, design, distribution, omnichannel access, and data capabilities to serve 6,100 unserved pin codes (Page 7).
- →Strategic acquisitions like GeoIQ to enhance geo-analytics for store expansions, especially internationally (Page 17).
- →Plans to accelerate international store openings as technology integration matures (Page 17).
- →Focus on backward integration and insourcing via Hyderabad plant to reduce costs amid currency headwinds (Page 9).
- →Investment in building a talent pool, especially engineering talent, to maintain speed and agility as the company scales (Page 13).
💰 Fundraising & Capital Structure
No information📋 Order Book & Pipeline
No informationKey Metrics
Revenue
Margin
Capex
Fundraise
Order Book
Continue your research
What Lenskart Solut.'s management said in earlier quarters
Others in Retailing this season
- Patel Retail Ltd (Q1 FY27)
INR 1 crore monthly revenue. Key concall takeaways from Patel Retail Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.
- Credo Brands Marketing Ltd (Q1 FY27)
Profit after tax for Q1 FY27 was modest (INR 2.3 crores with 1.8% PAT margin), reflecting a phase of reinvestment. Key concall takeaways from Credo Brands…
- Entero Healthcare Solutions Ltd (Q1 FY27)
Profit after tax (PAT) saw substantial growth in Q1, with a PAT margin of 2.7%; the company is focused on sustaining and building on this margin. Key concall…
- Aditya Birla Fashion & Retail Ltd (Q1 FY27)
10% space addition). Key concall takeaways from Aditya Birla Fashion & Retail Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.
Frequently Asked Questions
What were Lenskart Solut. Q1 FY27 results?
India market expected to grow significantly as penetration is only about 35%, with rising myopia and new segments like progressives and premium frames opening opportunities. Lenskart expects continued volume-led growth, driven by increasing eye tests (up 42.7% in India) and store expansions.
What is Lenskart Solut. share price analysis?
Lenskart Solut. currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 174.8 with a market cap of ₹115,038 Cr. Investors should review the full earnings analysis for detailed insights.
Is Lenskart Solut. planning capital expenditure?
₹132 crores plant capex related to Hyderabad manufacturing facility (Page 7).
Keep Lenskart Solut. on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.